Anti-dislodgment and anti-perforation distal tip design for transvenous lead

• US 5,755,767 A
• Filed: 08/02/1996
• Issued: 05/26/1998
• Est. Priority Date: 08/02/1996
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Gomperz, Benedict, Moaddeb, Shahram, Doan, Phong D.
• Primary Examiner(s): Cohen, Lee S.
• Application Number:
  US08/692,023
• Time in Patent Office: 662 Days
• Field of Search: 607/122, 607/126-128
• US Class Current: 607/126
• CPC Class Codes: A61N 1/0565 Electrode heads
• CPC Class Codes: A61N 1/057 Anchoring means; Means for fixing the head inside the heart

Abstract

A transvenous endocardial lead comprises an elongated flexible body member encompassing an electrical conductor which has an electrode at its distal end. A stabilizer adjacent the distal electrode extends outwardly from the flexible body member by a distance no greater than approximately one-half of the shortest distance between a longitudinal axis and the outer peripheral surface for minimizing dislodgment of the distal end from an intended implanted position into the myocardial tissue of the heart and for preventing penetration of the distal end of the flexible body member into the myocardial tissue. The stabilizer may be employed in conjunction with conventional active or passive fixation members and may take a variety of forms.

Claims

1. A transvenous endocardial lead for electrical stimulation of the heart, the lead having a length, the lead, comprising:

an elongated electrical conductor extending the length of the lead;

a flexible body member extending between proximal and distal ends thereof, said flexible body member having a longitudinal axis and an outer peripheral surface and surrounding the electrical conductor, said flexible body member having a lumen therein for receiving the electrical conductor;

electrically conductive electrode means secured to said distal end of said flexible body member and electrically connected to the electrical conductor for stimulating myocardial tissue of the heart; and

nonconducting stabilizing means adjacent said electrode means and extending outwardly from said outer peripheral surface by a distance no greater than approximately one-half of the shortest distance between the longitudinal axis and said outer peripheral surface for minimizing dislodgment of said distal end of said flexible body member from an intended implanted position and for preventing penetration of said distal end of said flexible body member into the myocardial tissue of the heart distally beyond said stabilizing means, wherein said stabilizing means includes a swellable collar fixed on and extending around the perimeter of said outer peripheral surface of said flexible body member adjacent said electrode means, said collar having an outer surface which, in a diminished condition, is generally flush with said outer peripheral surface and is expandable to a swelled condition projecting away from said outer peripheral surface, said collar being composed of a material which is generally inert to body fluids and tissue, which in the dry state remains in a diminished condition but which when exposed to body fluid will absorb the fluid and expand to the swelled condition, and which is pliant yet with sufficient rigidity to engage and be entrapped within fibrous tissue of the heart and prevent further distal travel of said endocardial lead into the myocardial tissue of the heart distally beyond said stabilizing means.

2. A transvenous endocardial lead, as set forth in claim 1:

wherein said flexible body member has a continuous groove in and encircling said peripheral surface and lying in a plane generally perpendicular to said longitudinal axis; and

wherein said swellable collar is embedded in the continuous groove and extends around the perimeter of said flexible body member adjacent said electrode means.

3. A transvenous endocardial lead, as set forth in claim 1, including passive fixation means for attaching said endocardial lead to the surface of the myocardial tissue of a heart to be stimulated.

4. A transvenous endocardial lead, as set forth in claim 3, wherein said passive fixation means includes nonconductive tine means on said flexible body member and extending from said outer peripheral surface at a plurality of spaced locations around the perimeter thereof distant from said electrode means for cooperating with the myocardial tissue of the heart to hold said flexible body member in position, said tine means forming a generally acute angle with said outer peripheral surface and being entirely of a pliant material having sufficient rigidity to maintain said angle when said tine means are unrestrained, but sufficiently pliant to prevent penetration of the myocardial tissue of the heart, said pliant material being generally inert to body fluids, said tine means preventing gross dislodgment of said body member relative to the heart, said stabilizing means preventing micro dislodgment of said distal end from the desired implanted position in the myocardial tissue of the heart.

5. A transvenous endocardial lead, as set forth in claim 1, including active fixation means for attaching said endocardial lead to the surface of a heart to be stimulated.

6. A transvenous endocardial lead, as set forth in claim 5, wherein said active fixation means includes a corkscrew distal end on said electrical conductor for penetrating the myocardial tissue of the heart to embed said endocardial lead therein.

7. A transvenous endocardial lead, as set forth in claim 1, wherein the nominal projected surface area of said electrode means is in the range of approximately 0.5 to 3.0 mm².